Clinical Trials Logo

Hypotension clinical trials

View clinical trials related to Hypotension.

Filter by:

NCT ID: NCT03397992 Completed - Acute Kidney Injury Clinical Trials

Low Dialysate Temperature During SLED

Start date: January 16, 2017
Phase: N/A
Study type: Interventional

Objectives: This study is evaluating the hemodynamic effects of lowering the dialysate temperature in acute kidney injury (AKI) patients submitted to sustained low efficiency dialysis (SLED) in a single large center. Methods: Participants will be randomly assigned to two treatment groups. One group will be started treatment with low temperature (set point 5 on the machine which is around 35°C) for one treatment and then alternate between high and low temperatures for a maximum of 8 treatments. The other group will be started with high temperature (set point 9 on the machine which is around 37°C) for the first treatment then alternate between high and low temperatures for a maximum of 8 treatments. Each participants will need at least two treatments, one with each temperature to be included in the analysis. The investigators will be looking for the number of events during a SLED treatment. Events will be defined as drop in systolic blood pressure ≥ 20 mmHg or drop in mean arterial pressure (MAP) of ≥10 mmHg, requirement of resuscitation with IVF after initiation of SLED, initiation or increase requirement of vasoactive drugs.

NCT ID: NCT03393559 Completed - Cerebral Ischemia Clinical Trials

Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position

Start date: January 24, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of leg elevation on the prevention of intraoperative hypotension during shoulder surgery in the Beach-chair position. patients undergoing shoulder surgery in the Beach-chair position will be randomly assigned to Group L (with leg elevation) or Group C (no intervention). The primary outcome is the incidence of intraoperative hypotension (mean blood pressure < 60mmHg or systolic blood pressure < 80% of baseline). Secondary outcomes are the incidence of intraoperative cerebral desaturation (cerebral oxygen saturation < 80% of baseline, longer than 30 seconds), total amounts of administered inotropic agents, and systolic blood pressure, heart rate, and cerebral oxygen saturation at various time points.

NCT ID: NCT03376347 Completed - Clinical trials for Intraoperative Hypotension

Intraoperative Implementation of the Hypotension Probability Indicator

HYPE
Start date: November 8, 2017
Phase: N/A
Study type: Interventional

Reducing intraoperative hypotension using FlotracIQ with HPI software.

NCT ID: NCT03354234 Completed - Hypoxia Clinical Trials

Evaluation of the ORTHO-LBNP System

ORTHO-LBNP
Start date: January 2, 2017
Phase: N/A
Study type: Interventional

The pilot study aims to evaluate a prototype system that enables military pilots to train under conditions of orthostatic hypotension and ischemic hypoxia. Both of these phenomena are experienced by aircraft crews of mainly highly maneuverable aircraft, and their syndromes include loss of color vision, loss of peripheral vision, blackout and finally G-induced loss of consciousness (G-LOC). A motorized tilt table to generate orthostatic (ORTHO) stress combined with an automatically controlled lower body negative pressure (LBNP) chamber to extort pooling of blood in the lower extremities has been developed in order to obtain new knowledge on counteracting the above-mentioned effects and minimizing the risk of their occurrence. This will help optimize the selection procedures of candidates with the best physiological predispositions to work as military pilots. The system is equipped with modules for monitoring biomedical parameters of a subject, including cerebral oxygenation, which ensures their safety and provides a source of data for performing advanced analyses. The ORTHO-LBNP system has been subjected to comprehensive laboratory tests and after a successful testing is ready for a pilot study involving pilots and/or cadets of the Polish Air Force Academy (PAFA). It is anticipated that new indicators will be proposed to enable an objective assessment of the predispositions to pursue a military pilot career. The prototype system can be easily adaptable to the needs of clinical and sports medicine as well as rehabilitation.

NCT ID: NCT03350659 Completed - Clinical trials for Neurogenic Orthostatic Hypotension

Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

Start date: January 1, 2018
Phase: Phase 4
Study type: Interventional

This was a randomized, open-label clinical trial. We will enroll patients with symptomatic neurogenic OH and randomize them to 1 of 2 treatments: (1) midodrine only, (2) atomoxetine only. We will follow up patients at 1 and 3 months after treatment. If the patients meet BP criteria for OH at 1 month, they will receive combination treatment with both midodrine and atomoxetin. The primary outcome measure is amelioration of questionnaire score evaluating OH-associated symptoms at 3 months. Secondary end-points were improvement in orthostatic blood pressure (BP) drop at 1 and 3 months.

NCT ID: NCT03320967 Completed - Clinical trials for Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients

COPNIC
Start date: December 4, 2017
Phase:
Study type: Observational

Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children`s Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission). These values will be primarily analysed for their variability and their association with arterial hypotension. Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm. Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine. Copeptin`s predictive value for patients` outcome will be analysed as secondary outcome.

NCT ID: NCT03318536 Completed - Hypotension Clinical Trials

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

Start date: October 5, 2017
Phase:
Study type: Observational

The aim of the present study is to quantify the dose and usage of sympathomimetics used in caesarean section.

NCT ID: NCT03296891 Completed - Hypotension Clinical Trials

Point of Care Ultrasonography In The Management of Shock: A Pilot Study

Start date: September 10, 2017
Phase: N/A
Study type: Interventional

This project aims to determine the feasibility of conducting a randomized controlled trial investigating point of care ultrasound guided resuscitation compared with usual care in the management of shock at the Critical Care Trauma Centre (CCTC) in London Health Science Centre (LHSC).

NCT ID: NCT03276494 Completed - Stroke Clinical Trials

Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

Start date: April 21, 2017
Phase: Phase 2
Study type: Interventional

Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.

NCT ID: NCT03274518 Completed - Clinical trials for Hemodialysis-Induced Symptom

Expanded Hemodialysis Versus Online Hemodiafiltration

Start date: November 13, 2017
Phase: N/A
Study type: Interventional

Conventional hemodialysis (HD) is essential for the treatment of end-stage renal disease (ESRD) patients, by reducing serum concentration of uremic toxins and correcting fluid overload. Nevertheless, HD removes almost exclusively low-range uremic toxins. Therefore, medium-range molecules, such as beta-2-microglobulin might accumulate in tissues, leading to many clinical complications, such as neuropathies, tendinopathies, anemia, bone mineral disease and reduced growth in children. Convective methods might reduce incidence of these complications, by removing molecules of medium-range molecular weight. Online hemodiafiltration (olHDF) is the most extensively used method in this regard. Nevertheless, there are some barriers to the wider introduction of this method in clinical practice, since specific machines are needed for this procedure, the costs with dialysis lines are higher and water consumption increases. More recently, the development of new membranes for hemodialysis allowed removal of medium- and high-range uremic toxins, with albumin retention. Thus, they allow removal of a broad range of uremic toxins, without changing dialysis machine or increasing water consumption. Such therapy is known as expanded hemodialysis (HDx). The aim of this present study is to compare the extraction of middle-size molecules, the hemodynamic behavior, fluid and nutritional status of patients submitted to olHDF or HDx, in a crossover study.